Evidence map›Paper›PMID 26328041›Full record

ArticleGastroenterology and hepatology from bed to bench2015

An in vitro model for hepatocyte-like cell differentiation from Wharton's jelly derived-mesenchymal stem cells by cell-base aggregates.

Tahereh Talaei-Khozani, Maryam Borhani-Haghighi, Maryam Ayatollahi, Zahra Vojdani

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology and hepatology from bed to bench, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Induction and Maturation of Hepatocyte-Like CellsFrontiers in cell and developmental biology · 2021
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Therapeutic potential of mesenchymal stem cells for diabetes.Journal of molecular endocrinology · 2017
    Review
  11. Article
  12. Review
  13. [Umbilical cord mesenchymal stem cells and their association with liver fibrosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2017
    Review
  14. Article
  15. Cell sources for in vitro human liver cell culture models.Experimental biology and medicine (Maywood, N.J.) · 2016
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tahereh Talaei-KhozaniLaboratory for stem cell research, Anatomy Department, Shiraz University of Medical sciences, Shiraz, Iran ; Tissue Engineering Lab, Tissue Engineering Department, School of Advanced Medical Science And Technology, Shiraz University of Medical sciences, Shiraz, Iran.
Maryam Borhani-HaghighiLaboratory for stem cell research, Anatomy Department, Shiraz University of Medical sciences, Shiraz, Iran.
Maryam AyatollahiTransplantation research center, Shiraz University of Medical Sciences, Shiraz, Ian.
Zahra VojdaniLaboratory for stem cell research, Anatomy Department, Shiraz University of Medical sciences, Shiraz, Iran.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe present study investigated the differentiation potential of human Umbilical Cord Mesenchymal Stem Cells (UCMSCs) into hepatic lineage through embryonic body-like aggregate formation in the presence of IGF-1.

backgroundCells derived from Wharton's jelly have been reported to display a wide multilineage differentiation potential, showing some similarities to both embryonic (ESC) and mesenchymal stem cells (MSCs). PATIENTS AND

methodsHuman MSCs isolated from the umbilical cord were plated in 20 μL micro drops. A two-step differentiation protocol was used and the cell aggregates were exposed to the media supplemented with IGF, HGF, oncostatin M, and dexamethasone for 21 days. Immunoperoxidase and immuno-fluorescence were performed for cyrokeratins 18, 19 and albumin. Functional assays were done by periodic acid Schiff (PAS) and indocyanine green.

resultsThe expression of cytokeratin 19 was shown to be higher in the cells derived from 3D spheroids compared to those cultured in conventional protocol. They showed a polygonal shape after being exposed to hepatogenic media. Immunostaining demonstrated the expression of cytokeratin-18, 19 and albumin by the differentiated cells. Besides, PAS staining revealed glycogen storage in differentiated cells. Also, a greater number of large size differentiated cells were found at the periphery of the expanded cell aggregates.

conclusionWe established a protocol for UCMSC differentiation into hepatocytes and these cells were morphologically and functionally similar to hepatocytes. Thus, hepatocyte differentiation may be facilitated by the UCMSCs aggregate formation before administration of the differentiation protocols.

Indexed as

Cell aggregateLiverMesenchymal stem cellsUmbilical cord

Identifiers

PMID26328041
PMCPMC4553159
OpenAlexW1935238044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.